Your browser doesn't support javascript.
loading
Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive.
Gudiol, Carlota; Hicklen, Rachel S; Okhyusen, Pablo C; Malek, Alexandre E; Kontoyiannis, Dimitrios P.
Affiliation
  • Gudiol C; Infectious Diseases Department, Bellvitge University Hospital, IDIBIELL, University of Barcelona, Barcelona, Spain.
  • Hicklen RS; Institut Català d'Oncologia, Barcelona, Spain.
  • Okhyusen PC; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), (CB21/13/00009), Instituto de Salud Carlos III, Madrid, Spain.
  • Malek AE; Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kontoyiannis DP; Division of Infectious Diseases, LSU Health Shreveport, Shreveport, Louisiana, USA.
Open Forum Infect Dis ; 9(11): ofac570, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36420059
ABSTRACT
Use of immune checkpoint inhibitors (ICIs), a revolutionary treatment in modern oncology, is frequently complicated by immune-related adverse events (irAEs), which can be confused with infections, and vice versa, thus complicating management decisions. In this study, we review the published cases of infections as simulators of irAEs in cancer patients.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Open Forum Infect Dis Year: 2022 Document type: Article Affiliation country: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Open Forum Infect Dis Year: 2022 Document type: Article Affiliation country: España